Literature DB >> 11040234

Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves.

W Wu1, Y Zhang, J R Ballew, G Fink, D H Wang.   

Abstract

Long-term administration of a subpressor dose of angiotensin II (Ang II) leads to pressor hyperresponsiveness and slow development of hypertension. Our preliminary data show that mRNA expression for calcitonin-gene related peptide in dorsal root ganglia was significantly increased by subpressor infusion of Ang II. To determine the role of sensory nerves in the development of hypertension induced by subpressor infusion of Ang II, newborn Wistar rats were given 50 mg/kg SC capsaicin on the 1st and 2nd days of life. After the weaning period, male rats were divided into 4 groups and subjected to the following treatments for 2 weeks: capsaicin+Ang II (150 ng. kg(-1). min(-1) SC by osmotic pumps, CAP-AII), capsaicin+vehicle (CAP), control+Ang II (CON-AII), and control+vehicle (CON). The results show that mean arterial pressure was significantly elevated in both Ang II-infused rats compared with non-Ang II-treated rats (P<0.05), and it was higher in CAP-AII than in CON-AII rats (P<0.05). The 24-hour urinary and sodium excretions were lower in CAP-AII than in CON-AII, CAP, and CON rats (P<0.05). These data demonstrated that sensory denervation exacerbates the development of hypertension and impairs renal excretory function when a subpressor dose of Ang II is given. These results indicate that activation of sensory nerves, either by Ang II or by other hormonal or hemodynamic factors, plays a compensatory role in promoting urine and sodium excretion and attenuating elevated blood pressure initiated by Ang II.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040234     DOI: 10.1161/01.hyp.36.4.549

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Intraneuronal angiotensinergic system in rat and human dorsal root ganglia.

Authors:  Jaspal Patil; Alexander Schwab; Juerg Nussberger; Thomas Schaffner; Juan M Saavedra; Hans Imboden
Journal:  Regul Pept       Date:  2010-03-24

2.  Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.

Authors:  Liang Xiao; Annet Kirabo; Jing Wu; Mohamed A Saleh; Linjue Zhu; Feng Wang; Takamune Takahashi; Roxana Loperena; Jason D Foss; Raymond L Mernaugh; Wei Chen; Jackson Roberts; John W Osborn; Hana A Itani; David G Harrison
Journal:  Circ Res       Date:  2015-07-08       Impact factor: 17.367

Review 3.  Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance.

Authors:  Robert Mkw Lee; Jeffrey G Dickhout; Shaun L Sandow
Journal:  Hypertens Res       Date:  2016-10-27       Impact factor: 3.872

4.  Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.

Authors:  Hans Imboden; Jaspal Patil; Juerg Nussberger; Françoise Nicoud; Benno Hess; Nermin Ahmed; Thomas Schaffner; Maren Wellner; Dominik Müller; Tadashi Inagami; Takaaki Senbonmatsu; Jaroslav Pavel; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-02-12

5.  The Characterization of AT1 Expression in the Dorsal Root Ganglia After Chronic Constriction Injury.

Authors:  Zuzana Oroszova; Ludmila Hricova; Andrea Stropkovska; Nadezda Lukacova; Jaroslav Pavel
Journal:  Cell Mol Neurobiol       Date:  2016-06-18       Impact factor: 5.046

6.  The Modulatory Role of Heme Oxygenase on Subpressor Angiotensin II-Induced Hypertension and Renal Injury.

Authors:  Kiran Chandrashekar; Arnaldo Lopez-Ruiz; Ramiro Juncos; Karl Nath; David E Stec; Trinity Vera; Ruisheng Liu; Luis A Juncos
Journal:  Int J Hypertens       Date:  2012-03-11       Impact factor: 2.420

7.  Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice.

Authors:  Wataru Nemoto; Osamu Nakagawasai; Fukie Yaoita; Syu-Ichi Kanno; Shin Yomogida; Masaaki Ishikawa; Takeshi Tadano; Koichi Tan-No
Journal:  Mol Pain       Date:  2013-07-31       Impact factor: 3.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.